Chronic Obstrutive Pulmonary Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: CCOPD patients; pulmonary function test values with forced expiratory volume in the first second (FEV1) / forced vital capacity (FVC) less than 0.7 and FEV1 less than 80% of predicted; associated with a history of drug treatment and signs and symptoms of COPD exacerbation; Typical HF signs and symptoms combined with a reduction in left ventricular (EF) fraction less than 50% by Doppler Echo, with forced expiratory volume in the first second (FEV1) / forced vital capacity (FVC) less than 0, 7 and lower FEV1 than 80% of the forecast).
Exclusion criteria
Exclusion criteria: Alcoholic patients and / or drug users who cause chemical dependency; patients using invasive mechanical ventilation; hemodynamic instability; presence of unstable angina; history of myocardial infarction in the last 6 months; patients who exacerbate again within the 30-day period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Endothelial and cardiac autonomic function will be more committed at coexistence of the diseases (FMD and arterial stiffness and heart rate variability measures) than when compared to isolated COPD in exacerbation phase. And the application of noninvasive ventilatory support in this exacerbation phase results acutely in beneficial responses to the endothelial and cardiac autonomic function. | — |
Secondary
| Measure | Time frame |
|---|---|
| The existence of an association between cardiovascular outcomes and clinical and functional aspects . | — |
Countries
Brazil
Contacts
Universidade Federal de São Carlos